Requires health insurers to cover colorectal cancer screenings for covered persons aged 33 or over and covered persons under the age of 33 if deemed medically necessary.
Summary
S4254 requires a broad set of New Jersey health coverage arrangements to pay for colorectal cancer screening without cost sharing for covered persons age 33 and older, and for younger covered persons when a physician deems the screening medically necessary. The bill amends multiple insurance and health benefits statutes covering hospital service corporations, medical service corporations, health service corporations, individual and group health policies, health benefits plans, HMO enrollee agreements, and the State Health Benefits, School Employees’ Health Benefits, and Medicaid programs.
The measure also requires coverage for a colonoscopy performed after a positive non-colonoscopy colorectal screening test, with no deductible, coinsurance, copayment, or other cost-sharing. The bill removes prior references tying coverage to United States Preventive Services Task Force recommendations and instead sets a specific annual screening mandate with a lower age threshold, while preserving physician medical-necessity determinations for younger patients.
Impact
The bill would expand mandated preventive coverage across most major New Jersey health insurance products and public coverage programs, requiring insurers and state-administered plans to reimburse one colorectal cancer screening per year for eligible enrollees. It would amend numerous sections of the insurance code and Medicaid law, thereby changing the minimum benefits that carriers and public programs must provide and limiting cost-sharing for follow-up colonoscopies after positive screening results. The bill applies prospectively to policies and contracts delivered, issued, executed, or renewed on or after its effective date.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes in the provided materials, the overall sentiment appears supportive of expanding access to preventive cancer screening. The sponsor’s framing suggests a public health and early-detection rationale, with the bill presented as a coverage expansion rather than a restriction. No opposing arguments, amendments, or recorded roll-call concerns are included in the available context.
Contention
The main policy issue embedded in the bill is the age threshold and the move away from the prior USPSTF-based standard. Requiring coverage beginning at age 33 is substantially broader than typical colorectal screening benchmarks, which may raise concerns for insurers and program administrators about utilization and cost. Another point of potential contention is the mandate for annual screening and the inclusion of Medicaid, State Health Benefits, and School Employees’ Health Benefits coverage, which could affect public spending and premium rates. The bill also leaves room for physician-determined medical necessity for younger patients, which may be viewed as either an important flexibility or a source of ambiguity in implementation.
Same As
Requires health insurers to cover colorectal cancer screenings for covered persons aged 33 or over and covered persons under the age of 33 if deemed medically necessary.